Campos Sara, Amaro Pedro, Portela Francisco, Sofia Carlos
Gastroenterology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
GE Port J Gastroenterol. 2016 Jun 21;23(4):183-190. doi: 10.1016/j.jpge.2016.02.007. eCollection 2016 Jul-Aug.
The risk of iatrogenic perforations in colonoscopy is not negligible. Experience with endoscopic closure of perforations is increasing and new devices for this purpose are being released, making endoscopy a therapeutic option. National data regarding iatrogenic perforations is scarce and the burden of iatrogenic perforations in out-hospital procedures is poorly characterized in the literature.
Evaluation of iatrogenic perforations rate during colonoscopy, their characteristics, management and prognosis.
Retrospective study of all patients with perforations secondary to in-hospital and non-hospital colonoscopies treated in a tertiary hospital between 01-01-2006 and 01-10-2014. Demographic, endoscopic, radiological and therapeutic data were analyzed.
Fifty-three perforations were identified, 20 occurring in colonoscopies performed in non-hospital environment (45% with therapeutic procedures) and 33 occurring in-hospital procedures (73% in therapeutic colonoscopies; representing 0.12% of all colonoscopies carried out in-hospital). Patients: male in 56%, average age of 71 years, history of previous abdominopelvic surgery in 31% and diverticulosis in 10%. Colonoscopy: elective in 93%, under deep sedation in 21%, with less than excellent/good bowel preparation in 56%. A resident was the first performer in 10 cases. Perforations: average size of 21 mm (4-130 mm), diagnosed during the procedure in 51% of cases and occurred in rectum-sigmoid transition in 58.5%. Regarding therapeutics, all patients with perforation occurring in non-hospital colonoscopies were managed by surgery. Concerning treatment of those in our unit: 2-conservative, 12-endoscopic (10 successfully), 21-surgical (including the 2 cases with failure of the endoscopic approach). Comparing endoscopic treatment (n = 10, G1) versus surgery (n = 21; G2): perforation size - 9 mm (G1) versus 28 mm (G2); perforation location - 7/10 in rectum-sigmoid (G1) versus 8/21 in rectum-sigmoid and 10/21 transverse/ascending colon/hepatic angle (G2). Morbidity: 1 infection in G1 and 13 complications in G2 (infection, hemorrhage, fistula). Mortality: no deaths in G1 and 2 deaths at 30 days due to septic shock in G2.
Perforations in colonoscopy are rare in our clinical practice. Endoscopic closure was effective, though limited to perforations found during the procedure. The mortality was relatively low and endoscopic management did not seem to worsen it. An additional effort is necessary in order to detect perforations during colonoscopy.
结肠镜检查中发生医源性穿孔的风险不可忽视。内镜下闭合穿孔的经验日益丰富,为此目的的新设备不断推出,使得内镜检查成为一种治疗选择。关于医源性穿孔的全国性数据稀缺,且院外操作中医源性穿孔的负担在文献中描述不足。
评估结肠镜检查期间医源性穿孔的发生率、特征、处理及预后。
对2006年1月1日至2014年10月1日在一家三级医院接受治疗的所有因院内和院外结肠镜检查继发穿孔的患者进行回顾性研究。分析人口统计学、内镜、放射学及治疗数据。
共识别出53例穿孔,20例发生在院外结肠镜检查中(45%为治疗性操作),33例发生在院内操作中(73%为治疗性结肠镜检查;占院内所有结肠镜检查的0.12%)。患者:男性占56%,平均年龄71岁,31%有既往腹部盆腔手术史,10%有憩室病。结肠镜检查:93%为择期检查,21%在深度镇静下进行,56%肠道准备不佳。10例由住院医师首次操作。穿孔:平均大小为21毫米(4 - 130毫米),51%的病例在操作过程中被诊断出,58.5%发生在直肠乙状结肠交界处。关于治疗,所有院外结肠镜检查中发生穿孔的患者均接受手术治疗。对于我院的患者:2例保守治疗,12例内镜治疗(10例成功),21例手术治疗(包括2例内镜治疗失败的病例)。比较内镜治疗组(n = 10,G1)与手术治疗组(n = 21;G2):穿孔大小 - G1组为9毫米,G2组为28毫米;穿孔位置 - G1组10例中有7例在直肠乙状结肠,G2组21例中有8例在直肠乙状结肠,10例在横结肠/升结肠/肝曲。发病率:G1组1例感染,G2组13例并发症(感染、出血、瘘)。死亡率:G1组无死亡,G2组30天内2例因感染性休克死亡。
在我们的临床实践中,结肠镜检查中的穿孔很少见。内镜闭合有效,但仅限于操作过程中发现的穿孔。死亡率相对较低,内镜治疗似乎并未使其恶化。为了在结肠镜检查期间检测到穿孔,还需要做出额外努力。